<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We wish to delineate a novel, and rapidly expanding, group of <z:e sem="disease" ids="C0025521" disease_type="Disease or Syndrome" abbrv="">inborn errors of metabolism</z:e> with neurological/muscular presentations: the defects in <z:chebi fb="1" ids="16247">phospholipids</z:chebi>, <z:chebi fb="0" ids="26739">sphingolipids</z:chebi> and <z:chebi fb="0" ids="15904">long chain fatty acids</z:chebi> biosynthesis </plain></SENT>
<SENT sid="1" pm="."><plain>At least 14 disorders have been described so far </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical presentations are diverse but can be divided into (1) diseases of the central <z:mp ids='MP_0008912'>nervous</z:mp> system; (2) <z:hpo ids='HP_0009830'>peripheral neuropathies</z:hpo>; and (3) muscular/cardiac presentations </plain></SENT>
<SENT sid="3" pm="."><plain>(1) <z:hpo ids='HP_0002415'>Leukodystrophy</z:hpo> and/or iron deposits in basal ganglia is a common feature of phospholipase A2 deficiency, fatty acid hydroxylase deficiency, and <z:chebi fb="0" ids="16454,29032">pantothenate</z:chebi> kinase-associated <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Infantile <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> has been reported in GM3 synthetase deficiency </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002510'>Spastic quadriplegia</z:hpo> with <z:hpo ids='HP_0008064'>ichthyosis</z:hpo> and <z:hpo ids='HP_0001249'>intellectual disability</z:hpo> are the presenting signs of the elongase 4 deficiency and the <z:e sem="disease" ids="C0037231" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Sjogren-Larsson syndrome</z:e> caused by fatty <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase deficiency </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001258'>Spastic paraplegia</z:hpo> and <z:hpo ids='HP_0003202'>muscle wasting</z:hpo> are also seen in patients with mutations in the <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> target esterase gene </plain></SENT>
<SENT sid="7" pm="."><plain>(2) <z:hpo ids='HP_0009830'>Peripheral neuropathy</z:hpo> is a prominent feature in PHARC syndrome due to α/β-hydrolase 12 deficiency, and in hereditary sensory <z:e sem="disease" ids="C0259749" disease_type="Disease or Syndrome" abbrv="">autonomic neuropathy</z:e> type I due to serine <z:chebi fb="0" ids="15525">palmitoyl-CoA</z:chebi> transferase deficiency </plain></SENT>
<SENT sid="8" pm="."><plain>(3) Muscular/cardiac presentations include <z:hpo ids='HP_0003652'>recurrent myoglobinuria</z:hpo> in phosphatidate phosphatase 1 (Lipin1) deficiency; <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and multivisceral involvement in <z:e sem="disease" ids="C0574083" disease_type="Disease or Syndrome" abbrv="">Barth syndrome</z:e> secondary to tafazzin mutations; <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> due to <z:chebi fb="3" ids="15354">choline</z:chebi> kinase deficiency, Sengers syndrome due to acylglycerol kinase deficiency and Chanarin Dorfman syndrome due to α/β- hydrolase 5 deficiency </plain></SENT>
<SENT sid="9" pm="."><plain>These synthesis defects of complex <z:chebi fb="23" ids="18059">lipid</z:chebi> molecules stand at the frontier between classical <z:e sem="disease" ids="C0025521" disease_type="Disease or Syndrome" abbrv="">inborn errors of metabolism</z:e> and other <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic diseases</z:e> involving the metabolism of structural proteins </plain></SENT>
</text></document>